{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:04:20Z","timestamp":1762459460004},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T00:00:00Z","timestamp":1483660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0169272","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T17:18:40Z","timestamp":1483982320000},"page":"e0169272","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer \u2013 A Retrospective Study"],"prefix":"10.1371","volume":"12","author":[{"given":"Veronika","family":"Seebacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Reinthaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Koelbl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Concin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Nehoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Polterauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,1,6]]},"reference":[{"key":"ref1","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/globocan.iarc.fr\" xlink:type=\"simple\">http:\/\/globocan.iarc.fr<\/ext-link>, accessed on 01\/08\/2016."},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"RE Bristow","year":"2002","journal-title":"J Clin Oncol"},{"issue":"17","key":"ref3","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group Study","volume":"21","author":"RF Ozols","year":"2003","journal-title":"J Clin Oncol"},{"issue":"Suppl.3","key":"ref4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bjc.6601494","article-title":"Primary ovarian cancer chemotherapy: current standards of care","volume":"89","author":"WP McGuire","year":"2003","journal-title":"Br J Cancer"},{"issue":"28","key":"ref5","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2009.21.9691","article-title":"Phase III trial of observation versus six courses of paclitaxel in patients with advanced epithelial ovarian cancer in complete response after six courses of paclitaxel\/platinum-based chemotherapy: final results of the After-6 Protocol 1","volume":"27","author":"S Pecorelli","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Group d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO)","volume":"115","author":"A Du Bois","year":"2009","journal-title":"Cancer"},{"issue":"34","key":"ref7","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2010.29.1351","article-title":"Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87\u201304 and 98\u201311","volume":"28","author":"E Ben-Josef","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0167-8140(02)00439-5","article-title":"The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy","volume":"67","author":"SW Chen","year":"2003","journal-title":"Radiother Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0959-8049(93)90169-G","article-title":"The impact of received dose intensity on the outcome of advanced ovarian cancer","volume":"29A","author":"L Repetto","year":"1993","journal-title":"Eur J Cancer"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2011.05.023","article-title":"Prognostic significance of the relative dose intensity of chemotherapy in primary treatment of epithelial ovarian cancer","volume":"122","author":"JM Fauci","year":"2011","journal-title":"Gynecologic Oncology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ygyno.2012.12.017","article-title":"Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer","volume":"129","author":"RK Hanna","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/0284186X.2015.1054950","article-title":"Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer\u2014a population-based study","volume":"55","author":"S Anuradha","year":"2016","journal-title":"Acta Oncol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2011.10.003","article-title":"Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer","volume":"124","author":"CI Nagel","year":"2012","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","article-title":"FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology","volume":"70","author":"JL Benedet","year":"2000","journal-title":"Int J Gyaecol Obstet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0959-8049(99)00259-2","article-title":"Chemotherapy dose reduction and delay in clinical practice: evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer","volume":"36","author":"J Chang","year":"2000","journal-title":"Eur J Cancer"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","article-title":"Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741\/Cancer and Leukemia Group B Trial 9741","volume":"21","author":"ML Citron","year":"2003","journal-title":"J Clin Oncol"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1470-2045(13)70363-2","article-title":"Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial","volume":"14","author":"N Katsumata","year":"2013","journal-title":"Lancet Oncol"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1470-2045(14)70049-X","article-title":"Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase-3-trial","volume":"15","author":"S Pignata","year":"2014","journal-title":"Lancet Oncol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1470-2045(09)70160-3","article-title":"Population-based differences in treatment outcome following anticancer drug therapies","volume":"11","author":"BB Ma","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"ref20","first-page":"63","article-title":"The application and outcome of standard of care treatment in elderly women with ovarian cancer: a literature review over the last 10 years","volume":"24","author":"SJ Gibson","year":"2016","journal-title":"Front Oncol"},{"issue":"28","key":"ref21","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"33","author":"TJ Smith","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0169272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T03:48:37Z","timestamp":1540266517000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0169272"}},"subtitle":[],"editor":[{"given":"Shian-Ying","family":"Sung","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,6]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0169272","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,6]]}}}